Skip to content
    Merck Global Health Innovation Fund logo

    Merck Global Health Innovation Fund

    Rahway, United StatesFounded 2010
    www.merckghifund.com
    HealthcareBiotech & Life SciencesData & Analytics

    Merck Global Health Innovation Fund (MGHIF) is the corporate venture capital arm of Merck & Co., founded in 2010 and based in Rahway, New Jersey. It is a growth investor partnering with innovative digital health and data science companies that facilitate and optimize biopharmaceutical operations and enhance patient care.

    49% of their portfolio is in Healthcare. Average disclosed round size is $43.1M (across 36 rounds with reported amounts).

    Find people at Merck Global Health Innovation Fund on Goldilocks AI

    Portfolio

    33

    Fund Size

    $500M

    Top Stage

    Unknown

    Last 12 Mo

    0

    Team

    BT

    Bill Taranto

    President & General Partner

    DR

    David Rubin

    Managing Director

    JV

    Joe Volpe

    VP / Managing Director

    JK

    Joel Krikston

    Managing Director Venture Investments

    PT

    Prem Tumkosit

    Managing Director

    AZ

    Alba Zurriaga Carda

    Director of Investments

    MM

    Michael Morgan

    Principal

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    41 investments
    CompanyRoundAmountDate
    PreciseDx logoPreciseDxUnknown$11MJun 2025
    QQure.aiSeries D$65MSep 2024
    QQure.aiSeries D—Jun 2024
    Cargosense logoCargosenseSeries A$8MJun 2024
    Delfi Diagnostics logoDelfi DiagnosticsUnknown—Jun 2024
    Atropos Health logoAtropos HealthSeries B—May 2024
    AAtroposSeries B$33MMay 2024
    Transcarent logoTranscarentSeries D$126MMay 2024
    Transcarent logoTranscarentSeries D$126MJan 2024
    Unnatural Products logoUnnatural ProductsSeries A$32MDec 2023
    AeroSafe Global logoAeroSafe GlobalGrowth$43MAug 2023
    AAeroSafeSeries F$43MAug 2023
    Prognos Health logoPrognos HealthGrowth$23MJan 2023
    Koneksa Health logoKoneksa HealthSeries C$45MFeb 2022
    Verana Health logoVerana HealthSeries E$150MJan 2022
    Transcarent logoTranscarentSeries C—Jan 2022
    PathAI logoPathAISeries C$165MMay 2021
    Antidote logoAntidoteSeed$5MJan 2021
    Volansi logoVolansiSeries B$50MSep 2020
    Tasso logoTassoSeries A$17MJul 2020
    Preventice Solutions logoPreventice SolutionsSeries B$137MJul 2020
    Navigating Cancer logoNavigating CancerUnknown$12MApr 2019
    TriNetX logoTriNetXSeries D$40MMar 2019
    Arcadia Healthcare Solutions logoArcadia Healthcare SolutionsGrowth$30MJan 2019
    Livongo logoLivongoUnknown$105MApr 2018
    Page 1 of 2

    Top Co-Investors

    Labcorp6 shared
    General Catalyst6 shared
    Human Ventures4 shared
    Threshold Ventures4 shared
    Kinnevik4 shared
    Ally Bridge Group4 shared
    Breyer Capital3 shared
    Novo Holdings A/S3 shared
    McKesson Ventures3 shared
    7wire Ventures3 shared
    Geodesic Capital3 shared
    Alta Partners3 shared
    Safeguard Scientifics, Inc.3 shared
    The Cigna Group Ventures3 shared
    Lightspeed Venture Partners2 shared
    Adage Capital Management2 shared
    Polaris Partners2 shared
    Casdin Capital2 shared
    The Venture Collective2 shared
    Martin Ventures2 shared

    Last updated: 8 September 2026